PCSK9 and coronary artery disorder: Several studies have revealed that loss-of-function mutations in PCSK9 culminate in low LDL-C levels and lead to a diminished risk of CAD (Benjannet et al., 2012; Seidah, 2017; Bayona et al., 2020).